Atb Cap Markets Cuts Earnings Estimates for Organigram

Organigram Holdings Inc. (TSE:OGIFree Report) – Research analysts at Atb Cap Markets decreased their FY2025 earnings per share estimates for Organigram in a research report issued on Monday, December 16th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.13) per share for the year, down from their prior estimate of ($0.12). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share.

Several other research firms have also commented on OGI. Canaccord Genuity Group dropped their target price on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a report on Monday, December 9th. ATB Capital decreased their target price on Organigram from C$5.25 to C$3.50 in a research note on Tuesday.

Read Our Latest Research Report on OGI

Organigram Stock Up 3.8 %

Shares of OGI traded up C$0.08 during midday trading on Thursday, hitting C$2.18. The company had a trading volume of 73,111 shares, compared to its average volume of 295,508. The company has a debt-to-equity ratio of 1.13, a quick ratio of 2.62 and a current ratio of 6.95. Organigram has a 1 year low of C$1.61 and a 1 year high of C$3.95. The firm has a market capitalization of C$236.68 million, a P/E ratio of -0.87, a P/E/G ratio of 0.42 and a beta of 1.13. The company’s 50-day simple moving average is C$2.26 and its 200-day simple moving average is C$2.30.

Insider Activity at Organigram

In related news, Senior Officer Paolo De Luca sold 12,014 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total transaction of C$30,275.28. Insiders own 31.32% of the company’s stock.

Organigram Company Profile

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Further Reading

Earnings History and Estimates for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.